Omar Abdel-Razek, Nhi Vo, Jeffrey Weinstein, Cyrus A Koldani, David Liu, Roger Laham
{"title":"Percutaneous Transcatheter Approach to Partial Anomalous Pulmonary Venous Return: A Case Series.","authors":"Omar Abdel-Razek, Nhi Vo, Jeffrey Weinstein, Cyrus A Koldani, David Liu, Roger Laham","doi":"10.1016/j.amjcard.2024.12.014","DOIUrl":null,"url":null,"abstract":"<p><p>Our study presents cases demonstrating the technique and safety of percutaneous occlusion of adult patients with partial anomalous pulmonary venous return (PAPVR). PAPVR is a rare condition that is traditionally treated surgically. Percutaneous interventions are rarely reported. Most patients with PAPVR present in youth and are surgical candidates. Among non-surgical candidates or those who prefer a percutaneous approach there is little available data to guide therapy. Patients with PAPVR and indications for intervention were treated with percutaneous techniques to occlude anomalous venous return and relieve the hemodynamic effects of these anomalies. Several different percutaneous techniques were used, sometimes in tandem to achieve occlusion. Percutaneous closure was achieved successfully in three cases with improvement in symptoms as well as improvement in hemodynamic status. Two patients achieved positive remodeling in right chamber sizes. In conclusion, Percutaneous occlusion of PAPVR is feasible with a multitude of transcatheter options available. This represents a novel approach to the adult patient with PAPVR, specifically those without a surgical option. Condensed Abstract: Partial anomalous pulmonary venous return (PAPVR) is a rare congenital condition which is traditionally treated surgically. Adult patients with congenital heart disease are potentially non-surgical candidates and as such benefit from percutaneous approaches. Our study describes the safety and feasibility of percutaneous closure of PAPVR as well as the positive impact on hemodynamic and chamber measures.</p>","PeriodicalId":7705,"journal":{"name":"American Journal of Cardiology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjcard.2024.12.014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Our study presents cases demonstrating the technique and safety of percutaneous occlusion of adult patients with partial anomalous pulmonary venous return (PAPVR). PAPVR is a rare condition that is traditionally treated surgically. Percutaneous interventions are rarely reported. Most patients with PAPVR present in youth and are surgical candidates. Among non-surgical candidates or those who prefer a percutaneous approach there is little available data to guide therapy. Patients with PAPVR and indications for intervention were treated with percutaneous techniques to occlude anomalous venous return and relieve the hemodynamic effects of these anomalies. Several different percutaneous techniques were used, sometimes in tandem to achieve occlusion. Percutaneous closure was achieved successfully in three cases with improvement in symptoms as well as improvement in hemodynamic status. Two patients achieved positive remodeling in right chamber sizes. In conclusion, Percutaneous occlusion of PAPVR is feasible with a multitude of transcatheter options available. This represents a novel approach to the adult patient with PAPVR, specifically those without a surgical option. Condensed Abstract: Partial anomalous pulmonary venous return (PAPVR) is a rare congenital condition which is traditionally treated surgically. Adult patients with congenital heart disease are potentially non-surgical candidates and as such benefit from percutaneous approaches. Our study describes the safety and feasibility of percutaneous closure of PAPVR as well as the positive impact on hemodynamic and chamber measures.
期刊介绍:
Published 24 times a year, The American Journal of Cardiology® is an independent journal designed for cardiovascular disease specialists and internists with a subspecialty in cardiology throughout the world. AJC is an independent, scientific, peer-reviewed journal of original articles that focus on the practical, clinical approach to the diagnosis and treatment of cardiovascular disease. AJC has one of the fastest acceptance to publication times in Cardiology. Features report on systemic hypertension, methodology, drugs, pacing, arrhythmia, preventive cardiology, congestive heart failure, valvular heart disease, congenital heart disease, and cardiomyopathy. Also included are editorials, readers'' comments, and symposia.